News | bioMérieux

bioMérieux – First-Half 2019 Results

04 September, 2019

bioMérieux increases its holding in Hybiome from 54% to 67%

06 June, 2019

Baxter and bioMérieux announce collaboration to improve identification and treatment of acute kidney injury

19 March, 2019

“Global-PPS”, a survey of antibiotic use and bacterial resistance in hospitals worldwide, tops the 200,000 patients

19 March, 2019

bioMérieux launches the BIOFIRE^® FILMARRAY^® Pneumonia Panels with FDA clearance and CE Marking

13 November, 2018

bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market

09 November, 2018

bioMérieux – First-Half 2018 Results

05 September, 2018

bioMérieux – Second-Quarter 2018 Business Review

18 July, 2018

bioMérieux launches ENDOZYME^® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control

31 May, 2018

NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in Groundbreaking Consensus Statement of Best Practices to Enhance Recovery after Heart Surgery

02 May, 2018

Pioneering Diagnostics